Foto del docente

Vittorio Stefoni

Ricercatore confermato

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MED/15 MALATTIE DEL SANGUE

Pubblicazioni

Zinzani PL; Gandolfi L; Broccoli A; Argnani L; Fanti S; Pellegrini C; Stefoni V; Derenzini E; Quirini F; Baccarani M., Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma., «CANCER», 2011, 117, pp. 1010 - 1018 [articolo]

Lopci E; Santi I; Tani M; Maffione AM; Montini G; Castellucci P; Stefoni V; Rubello D; Fonti C; Zinzani P; Fanti S., FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma., «THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2010, 54, pp. 436 - 441 [articolo]

Zinzani PL; Broccoli A; Stefoni V; Musuraca G; Abruzzese E; De Renzo A; Cantonetti M; Bacci F; Baccarani M; Pileri SA., Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients., «CANCER», 2010, 116, pp. 5667 - 5675 [articolo]

Zinzani P.L.; Rossi G.; Franceschetti S.; Botto B.; Di Rocco A.; Cabras M.G.; Petti M.C.; Stefoni V.; Broccoli A.; Fanti S.; Pellegrini C.; Montini G.C.; Gandolfi L.; Derenzini E.; Argnani L.; Fina M.; Tucci A.; Bottelli C.; Pileri S.; Baccarani M., Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients., «CLINICAL CANCER RESEARCH», 2010, 16(15), pp. 3998 - 4004 [articolo]

Derenzini E; Stefoni V; Pellegrini C; Fina MP; Broccoli A; Venturini F; Gandolfi L; Pileri SA; Martelli M; Petti MC; Perrotti A; De Renzo A; Zaja F;Baccarani M; Zinzani PL., Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma. Leuk Lymphoma., «LEUKEMIA & LYMPHOMA», 2009, 50(11), pp. 1824 - 1829 [articolo]

Zinzani P.L.; Stefoni V.; Tani M.; Fanti S.; Musuraca G.; Castellucci P.; Marchi E.; Fina M.; Ambrosini V.; Pellegrini C.; Alinari L.; Derenzini E.; Montini G.; Broccoli A.; Bacci F.; Pileri S.; Baccarani M., Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma, «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27(11), pp. 1781 - 1787 [articolo]

Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pellegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M., A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients., «ANNALS OF ONCOLOGY», 2008, 19, pp. 769 - 773 [articolo]

Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M., A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma, «CANCER», 2008, 112(4), pp. 856 - 862 [articolo]

Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M., Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)., «THE LANCET ONCOLOGY», 2008, 9, pp. 352 - 358 [articolo]

Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL., Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma., «CANCER», 2008, 113(9), pp. 2496 - 2503 [articolo]

. S. Tsamita, A. Golemi, V. Stefoni, P. Castellucci, M. Farsad, G. Montini, C. Nanni, C. Pellegrini, V. Ambrosini, D. Rubello, R. Franchi, P. Zinzani, S. Fanti;, Clinical significance of axillary findings in patients with lymphoma during follow up. C, in: , «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2007, 34(suppl 2), pp. s164. - s164. (atti di: EANM 2007, Copenhagen, 13-17 October 2007) [atti di convegno-abstract]

V. Ambrosini; P.L. Zinzani; P. Castellucci; V. Stefoni; C. Nanni; M. Tani; M. Farsad; L. Alinari; D. Rubello; R. Franchi; S. Fanti, FDG-PET in the serial assessment of patinets with lymphoma in complete remission, in: SOCIETY OF NUCLEAR MEDICINE, Supplement ot the Journal of Nuclear Medicine Abstract Book, RESTON, VA, Society of Nuclear Medicine, 2007, 48 (2), pp. 182p - 182p (atti di: Society of Nuclear Medicine Annual Meeting, Washington, USA, 1-6 June 2007) [atti di convegno-abstract]

Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpiaz G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M., Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma., «HAEMATOLOGICA», 2007, 92, pp. 771 - 777 [articolo]

Alinari L.; Ambrosini V.; Castellucci P.; Tani M.; Stefoni V.; Nanni C.; Farsad M.; Rubello D.; Franchi R.; Zinzani P.L.; Fanti S., Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients., «LEUKEMIA & LYMPHOMA», 2006, 47(6), pp. 1048 - 1052 [articolo]

Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; Fina M.; Farshad M.; Pileri S.; Baccarani M., Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients., «ANNALS OF ONCOLOGY», 2006, 17, pp. 1296 - 1300 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.